Related Experiment Video

Updated: Jun 17, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Targeting the EGF receptor for ovarian cancer therapy

Reema Zeineldin1, Carolyn Y Muller, M Sharon Stack

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131-0001, USA.

Journal of Oncology
|January 13, 2010
PubMed

Insights

Ovarian cancer is a leading cause of gynecologic cancer deaths. This review explores how epidermal growth factor (EGF) receptor activation contributes to ovarian cancer and discusses targeted therapies for treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gynecology

Background:

  • Ovarian carcinoma presents a significant mortality rate in the US.
  • Tumor molecular heterogeneity and late-stage diagnosis impede effective ovarian cancer treatment.
  • Targeted therapies are increasingly important for cancer treatment.

Purpose of the Study:

  • To review the role of epidermal growth factor (EGF) receptor activation in ovarian cancer development.
  • To summarize the current status of EGF receptor inhibitors and targeted therapies for ovarian cancer.

Main Methods:

  • Literature review of studies on EGF receptor signaling in ovarian cancer.
  • Analysis of clinical trial data for EGF receptor inhibitors in ovarian cancer treatment.

Main Results:

  • EGF receptor pathway activation is implicated in ovarian cancer pathogenesis.
  • EGF receptor inhibitors show potential as targeted therapies for ovarian cancer.

Conclusions:

  • Targeting the EGF receptor pathway offers a promising strategy for ovarian cancer management.
  • Further research and clinical trials are needed to optimize EGF receptor-targeted therapies.

More Related Videos

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-107:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...